Want to see ALLO full AI Analyst Report?
ETFs with Allogene Therapeutics (ALLO) Exposure
The following ETFs maintain exposure to Allogene Therapeutics (ALLO). ETF holdings data are updated once a day, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
51 ETFs Hold Allogene Therapeutics (ALLO)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in ALLO |
|---|---|---|---|---|---|---|
| MOON | ― | ― | ― | 2.24% | $433.87K | 0.04% |
| CHNA | ― | ― | ― | 1.05% | $39.20K | <0.01% |
| NIFE | ― | ― | ― | 0.99% | $22.46K | <0.01% |
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | 0.48% | $165.95K | 0.04% |
| WDNA | WisdomTree BioRevolution Fund | $5.18M | 0.45% | 0.41% | $20.78K | <0.01% |
| WDNA | WisdomTree BioRevolution UCITS ETF AccumUSD | $52.82M | 0.46% | 0.39% | $170.11K | 0.04% |
| SBIO | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | 0.27% | $495.32K | 0.12% |
| RUSC | US Small Cap Equity Active ETF | $85.25M | 0.64% | 0.20% | $159.18K | 0.02% |
| BUSM | EA Bridgeway Ultra-Small Company Market ETF | $115.26M | 0.73% | 0.13% | $152.09K | 0.04% |
| TMED | T. Rowe Price Health Care ETF | $34.83M | 0.44% | 0.12% | $43.45K | 0.01% |
| XBI | SPDR S&P BIOTECH ETF | $11.05B | 0.35% | 0.11% | $12.09M | 2.80% |
| MEDX | Horizon Kinetics Medical ETF | $17.76M | 0.85% | 0.11% | $18.95K | <0.01% |
| WMGT | WisdomTree Megatrends UCITS ETF Accum USD | $67.79M | 0.57% | 0.08% | $53.85K | 0.01% |
| VMO | Vanguard GlbMomntFac | $490.96M | 0.44% | 0.07% | $340.63K | 0.03% |
| KOMP | SPDR S&P Kensho New Economies Composite ETF | $2.57B | 0.20% | 0.06% | $1.64M | 0.38% |
| ZGEN | ― | ― | ― | 0.06% | $1,681.7 | <0.01% |
| FESM | Fidelity Enhanced Small Cap ETF | $6.85B | 0.28% | 0.04% | $2.70M | 0.63% |
| FSEV | Fidelity Enhanced Small Cap Value ETF | $7.98M | 0.28% | 0.04% | $2,955 | <0.01% |
| SMLF | iShares MSCI USA Small-Cap Multifactor ETF | $4.28B | 0.15% | 0.04% | $1.53M | 0.36% |
| PRFZ | Invesco FTSE RAFI US 1500 Small-Mid ETF | $2.71B | 0.36% | 0.03% | $787.31K | 0.19% |
| VTWV | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | 0.03% | $385.83K | 0.07% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.03% | $359.08K | 0.08% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.03% | $31.30K | <0.01% |
| VFMO | Vanguard U.S. Momentum Factor ETF | $1.93B | 0.13% | 0.03% | $484.36K | 0.11% |
| PWS | Pacer WealthShield ETF | $14.55M | 0.60% | 0.02% | $3,293.75 | <0.01% |
| IWN | iShares Russell 2000 Value ETF | $14.23B | 0.24% | 0.02% | $3.08M | 0.71% |
| ZINN | ― | ― | ― | 0.02% | $1,907.76 | <0.01% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 0.02% | $2.20M | 0.54% |
| DFMC | U.S. Micro Cap Portfolio ETF | $211.48M | 0.41% | 0.01% | $1.25M | 0.19% |
| VRSD | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | 0.01% | $2,070.4 | <0.01% |
| VTWO | Vanguard Russell 2000 ETF | $17.04B | 0.06% | 0.01% | $2.47M | 0.45% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | $270.82M | 0.39% | 0.01% | $32.90K | <0.01% |
| R2EH | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | 0.01% | $595.77K | 0.14% |
| IWM | iShares Russell 2000 ETF | $76.76B | 0.19% | 0.01% | $8.49M | 1.97% |
| RTYS | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | 0.01% | $35.26K | <0.01% |
| RSSL | Global X Russell 2000 ETF | $1.47B | 0.08% | 0.01% | $160.23K | 0.04% |
| RESM | Columbia Research Enhanced Small Cap ETF | $5.96M | 0.32% | 0.01% | $645 | <0.01% |
| ITWO | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | 0.01% | $18.73K | <0.01% |
| RB | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | <0.01% | $111.25 | <0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | <0.01% | $1.78M | 0.41% |
| DFAS | Dimensional U.S. Small Cap ETF | $15.58B | 0.26% | <0.01% | $2.12M | 0.49% |
| VHT | Vanguard Health Care ETF | $20.70B | 0.09% | <0.01% | $1.26M | 0.23% |
| VXF | Vanguard Extended Market ETF | $30.86B | 0.05% | <0.01% | $4.97M | 0.90% |
| HDG | ProShares Hedge Replication ETF | $22.40M | 0.95% | <0.01% | $403.75 | <0.01% |
| VTI | Vanguard Total Stock Market ETF | $701.51B | 0.03% | <0.01% | $13.87M | 2.51% |
| VTHR | Vanguard Russell 3000 ETF | $4.90B | 0.06% | <0.01% | $35.69K | <0.01% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | <0.01% | $447.02K | 0.10% |
| SCHB | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | <0.01% | $191.37K | 0.04% |
| DFAC | Dimensional U.S. Core Equity 2 ETF | $49.92B | 0.17% | <0.01% | $301.60K | 0.07% |
| IWV | iShares Russell 3000 ETF | $20.56B | 0.20% | <0.01% | $32.24K | <0.01% |
| DDUM | Dimensional Funds ICAV - Dimensional US Core Equity Market UCITS ETF USD Acc | ― | 0.16% | <0.01% | $27.5 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in ALLO |
|---|---|---|---|---|---|---|
| MOON | 2.24% | ― | ― | ― | $433.87K | 0.04% |
| CHNA | 1.05% | ― | ― | ― | $39.20K | <0.01% |
| NIFE | 0.99% | ― | ― | ― | $22.46K | <0.01% |
| BBC | 0.48% | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | $165.95K | 0.04% |
| WDNA | 0.41% | WisdomTree BioRevolution Fund | $5.18M | 0.45% | $20.78K | <0.01% |
| WDNA | 0.39% | WisdomTree BioRevolution UCITS ETF AccumUSD | $52.82M | 0.46% | $170.11K | 0.04% |
| SBIO | 0.27% | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | $495.32K | 0.12% |
| RUSC | 0.20% | US Small Cap Equity Active ETF | $85.25M | 0.64% | $159.18K | 0.02% |
| BUSM | 0.13% | EA Bridgeway Ultra-Small Company Market ETF | $115.26M | 0.73% | $152.09K | 0.04% |
| TMED | 0.12% | T. Rowe Price Health Care ETF | $34.83M | 0.44% | $43.45K | 0.01% |
| XBI | 0.11% | SPDR S&P BIOTECH ETF | $11.05B | 0.35% | $12.09M | 2.80% |
| MEDX | 0.11% | Horizon Kinetics Medical ETF | $17.76M | 0.85% | $18.95K | <0.01% |
| WMGT | 0.08% | WisdomTree Megatrends UCITS ETF Accum USD | $67.79M | 0.57% | $53.85K | 0.01% |
| VMO | 0.07% | Vanguard GlbMomntFac | $490.96M | 0.44% | $340.63K | 0.03% |
| KOMP | 0.06% | SPDR S&P Kensho New Economies Composite ETF | $2.57B | 0.20% | $1.64M | 0.38% |
| ZGEN | 0.06% | ― | ― | ― | $1,681.7 | <0.01% |
| FESM | 0.04% | Fidelity Enhanced Small Cap ETF | $6.85B | 0.28% | $2.70M | 0.63% |
| FSEV | 0.04% | Fidelity Enhanced Small Cap Value ETF | $7.98M | 0.28% | $2,955 | <0.01% |
| SMLF | 0.04% | iShares MSCI USA Small-Cap Multifactor ETF | $4.28B | 0.15% | $1.53M | 0.36% |
| PRFZ | 0.03% | Invesco FTSE RAFI US 1500 Small-Mid ETF | $2.71B | 0.36% | $787.31K | 0.19% |
| VTWV | 0.03% | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | $385.83K | 0.07% |
| OM3E | 0.03% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $359.08K | 0.08% |
| IBBQ | 0.03% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $31.30K | <0.01% |
| VFMO | 0.03% | Vanguard U.S. Momentum Factor ETF | $1.93B | 0.13% | $484.36K | 0.11% |
| PWS | 0.02% | Pacer WealthShield ETF | $14.55M | 0.60% | $3,293.75 | <0.01% |
| IWN | 0.02% | iShares Russell 2000 Value ETF | $14.23B | 0.24% | $3.08M | 0.71% |
| ZINN | 0.02% | ― | ― | ― | $1,907.76 | <0.01% |
| IBB | 0.02% | iShares Biotechnology ETF | $11.52B | 0.44% | $2.20M | 0.54% |
| DFMC | 0.01% | U.S. Micro Cap Portfolio ETF | $211.48M | 0.41% | $1.25M | 0.19% |
| VRSD | 0.01% | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | $2,070.4 | <0.01% |
| VTWO | 0.01% | Vanguard Russell 2000 ETF | $17.04B | 0.06% | $2.47M | 0.45% |
| OMFS | 0.01% | Invesco Russell 2000 Dynamic Multifactor ETF | $270.82M | 0.39% | $32.90K | <0.01% |
| R2EH | 0.01% | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | $595.77K | 0.14% |
| IWM | 0.01% | iShares Russell 2000 ETF | $76.76B | 0.19% | $8.49M | 1.97% |
| RTYS | 0.01% | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | $35.26K | <0.01% |
| RSSL | 0.01% | Global X Russell 2000 ETF | $1.47B | 0.08% | $160.23K | 0.04% |
| RESM | 0.01% | Columbia Research Enhanced Small Cap ETF | $5.96M | 0.32% | $645 | <0.01% |
| ITWO | 0.01% | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | $18.73K | <0.01% |
| RB | <0.01% | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | $111.25 | <0.01% |
| SCHA | <0.01% | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | $1.78M | 0.41% |
| DFAS | <0.01% | Dimensional U.S. Small Cap ETF | $15.58B | 0.26% | $2.12M | 0.49% |
| VHT | <0.01% | Vanguard Health Care ETF | $20.70B | 0.09% | $1.26M | 0.23% |
| VXF | <0.01% | Vanguard Extended Market ETF | $30.86B | 0.05% | $4.97M | 0.90% |
| HDG | <0.01% | ProShares Hedge Replication ETF | $22.40M | 0.95% | $403.75 | <0.01% |
| VTI | <0.01% | Vanguard Total Stock Market ETF | $701.51B | 0.03% | $13.87M | 2.51% |
| VTHR | <0.01% | Vanguard Russell 3000 ETF | $4.90B | 0.06% | $35.69K | <0.01% |
| ITOT | <0.01% | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | $447.02K | 0.10% |
| SCHB | <0.01% | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | $191.37K | 0.04% |
| DFAC | <0.01% | Dimensional U.S. Core Equity 2 ETF | $49.92B | 0.17% | $301.60K | 0.07% |
| IWV | <0.01% | iShares Russell 3000 ETF | $20.56B | 0.20% | $32.24K | <0.01% |
| DDUM | <0.01% | Dimensional Funds ICAV - Dimensional US Core Equity Market UCITS ETF USD Acc | ― | 0.16% | $27.5 | <0.01% |
Popular ETF Comparisons
ALLO ETF Exposure FAQ
What ETFs hold Allogene Therapeutics stock?
Allogene Therapeutics (ALLO) is currently held by 51 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to ALLO include ALPS (SBIO), MOON and WisdomTree (GB:WDNA).
Which ETF has the largest exposure to ALLO?
The ETF with the largest exposure to ALLO is ALPS (SBIO), with approximately $495.32K in market value exposure.
How much ALLO stock is held by ETFs?
ETFs currently hold approximately $1.70M worth of Allogene Therapeutics (ALLO) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.